Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy

D. Choy (South San Francisco, United States of America), N. Trivedi (San Francisco, United States of America), A. Dressen (South San Francisco, United States of America), M. Babina (Berlin, Germany), R. Ahuja (San Francisco, United States of America), T. Yi (South San Francisco, United States of America), J. Jackman (South San Francisco, United States of America), G. Ji (South San Francisco, United States of America), J. Hackney (South San Francisco, United States of America), L. Orozco-Guerra (South San Francisco, United States of America), D. Chang (South San Francisco, United States of America), G. Caughey (San Francisco, United States of America), B. Yaspan (San Francisco, United States of America)

Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1652
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Choy (South San Francisco, United States of America), N. Trivedi (San Francisco, United States of America), A. Dressen (South San Francisco, United States of America), M. Babina (Berlin, Germany), R. Ahuja (San Francisco, United States of America), T. Yi (South San Francisco, United States of America), J. Jackman (South San Francisco, United States of America), G. Ji (South San Francisco, United States of America), J. Hackney (South San Francisco, United States of America), L. Orozco-Guerra (South San Francisco, United States of America), D. Chang (South San Francisco, United States of America), G. Caughey (San Francisco, United States of America), B. Yaspan (San Francisco, United States of America). Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy. 1652

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: